PureTech Health plc (NASDAQ:PRTC – Get Free Report)’s stock price gapped down prior to trading on Thursday . The stock had previously closed at $24.32, but opened at $23.59. PureTech Health shares last traded at $23.59, with a volume of 369 shares changing hands.
PureTech Health Price Performance
The stock has a 50-day moving average price of $27.50 and a 200 day moving average price of $26.48.
Institutional Investors Weigh In On PureTech Health
A hedge fund recently bought a new stake in PureTech Health stock. AWM Investment Company Inc. purchased a new stake in shares of PureTech Health plc (NASDAQ:PRTC – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 6,900 shares of the company’s stock, valued at approximately $197,000. 0.04% of the stock is currently owned by hedge funds and other institutional investors.
About PureTech Health
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Read More
- Five stocks we like better than PureTech Health
- Comparing and Trading High PE Ratio Stocks
- Sales Breakout Sends This Semiconductor Stock to Record High
- Profitably Trade Stocks at 52-Week Highs
- Surprise Buying Opportunity on This Dividend Aristocrat
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
